Vietnam Peritoneal Dialysis Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Market Overview

The Vietnam Peritoneal Dialysis Market is projected to grow from USD 26.42 million in 2023 to USD 45.49 million by 2032, registering a compound annual growth rate (CAGR) of 6.52% over the forecast period.

The market is primarily driven by the rising prevalence of chronic kidney disease (CKD) and growing awareness of alternative renal therapies. With an increasing number of CKD cases, there is a growing demand for peritoneal dialysis due to its cost-effectiveness and ease of use, especially in rural and underserved regions. Government-backed initiatives to strengthen healthcare infrastructure and improve access to dialysis treatment are significantly contributing to market growth.

Moreover, advancements in dialysis technologies—particularly the adoption of automated peritoneal dialysis (APD) systems—are improving treatment efficiency and enhancing patient outcomes, leading to broader adoption. Rising healthcare expenditure, along with improved reimbursement frameworks, is further propelling the market. The shift towards home-based dialysis is also gaining momentum, offering patients greater convenience and reducing pressure on hospital-based dialysis services.
Key Market Drivers
1. Government Support and Policy Initiatives

The Vietnamese government has taken proactive steps to enhance healthcare access and quality, which has positively impacted the peritoneal dialysis sector. Key measures include increased funding for public health programs, expansion of dialysis facilities, and the implementation of reimbursement policies for renal treatments. For example, the Ministry of Health’s collaboration with Novartis to strengthen primary care and manage non-communicable diseases has significantly improved accessibility to kidney care at the community level. These initiatives are critical in expanding the reach of peritoneal dialysis services, particularly in rural and remote areas.
Market Challenges
1. High Cost of Equipment and Consumables

Despite its benefits, the high cost of peritoneal dialysis equipment and ongoing treatment remains a substantial barrier to market expansion. Devices such as automated peritoneal dialysis (APD) machines and associated components like dialysis catheters are often prohibitively expensive, especially for low- to middle-income households. For example, the cost of a single APD machine in Vietnam can exceed the average annual income of many families. Additionally, the recurring expenses for dialysis solutions and consumables further increase the financial burden. These cost challenges limit access, particularly for patients who lack sufficient insurance coverage or government support.
Market Segmentation
By Type:

Continuous Ambulatory Peritoneal Dialysis (CAPD)

Automated Peritoneal Dialysis (APD)

By Product:

Peritoneal Dialysis Machines

Peritoneal Dialysis Solutions

Dialysis Catheters

Others

By End-user:

Hospitals

Dialysis Centers

Home Care Settings

By Region:

Southeast Vietnam

Northern Vietnam

Central Vietnam

Southern Vietnam

Key Players in the Market

Leading companies operating in the Vietnam peritoneal dialysis market include:

Nipro Corporation

Baxter International Inc.

Fresenius Medical Care

Terumo Corporation

Asahi Kasei Medical Co., Ltd.

Huaren Pharmaceutical Co., Ltd.

JMS Co., Ltd.

Kawasumi Laboratories Inc.

Medtronic plc

Pacific Hospital Supply Co., Ltd.